|Tel||+44 (0)1865 289277|
- NIHR Doctoral Research Fellow
Seamus is an NIHR Doctoral Research Fellow studying the impact of overweight and obesity on long-term health and healthcare resource use using the Million Women Study and linked administrative data sets.
Seamus joined HERC in November 2012 to develop health economics research using data from two large contemporary clinical trials, HPS2-THRIVE and SHARP. His research focused on estimating the impacts of adverse events, demographic characteristics and common risk factors on healthcare costs and health-related quality of life in populations at increased cardiovascular disease risk, and, in the case of SHARP, a population with chronic kidney disease.
Seamus graduated with a BSc in Economics in 2009 and was awarded an MSc in Health Economics at the University of York in 2010 and an MSc in Medical Statistics at the University of Leicester in 2013.
The Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin with Laropiprant on Health and Healthcare Costs
Mihaylova BN. et al, (2016), Circulation: Cardiovascular Quality and Outcomes
Effects of Vascular and Nonvascular Adverse Events and of Extended-Release Niacin With Laropiprant on Health and Healthcare Costs
Seamus Kent et al, (2016), Circulation: Cardiovascular Quality and Outcomes
Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP)
Mihaylova B. et al, (2015), American Journal of Kidney Diseases
Mapping from the Parkinson's Disease Questionnaire PDQ-39 to the Generic EuroQol EQ-5D-3L: The Value of Mixture Models.
Kent S. et al, (2015), Med Decis Making, 35, 902 - 911
What is the impact of chronic kidney disease stage and cardiovascular disease on the annual cost of hospital care in moderate-to-severe kidney disease?
Kent S. et al, (2015), BMC Nephrol, 16